The reported decrease in both EPS and sales for Neonode is a clear indicator of the company's current financial health and operational challenges. A 55.56% decrease in EPS and a 19.07% decrease in sales year-over-year are significant metrics that investors consider when assessing a company's performance and future prospects. Such declines are typically viewed negatively by the market, potentially leading to a decrease in stock price in the short term.